Abstract
A 5-year randomized study to investigate the safety of pimecrolimus cream 1% in the treatment of mild-to-moderate atopic dermatitis in infants: Clinical safety
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have